THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2

Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JETTE, Claudia A, WANG, Jingzhou, VIELMETTER, Jost G, CHARTRON, Justin W, BARNES, Christopher O, CONTRERAS, Stephanie C, WEST, JR, CHANG, Paul M, BJORKMAN, Pamela J, KEEFFE, Jennifer R, MAYO, Stephen L, ACEVES, Aiden J, OLAFSON, Barry D
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des anticorps ou des fragments de ceux-ci ayant une spécificité vis-à-vis d'une protéine de spicule de sarbecovirus. L'invention concerne également des compositions, des méthodes et des kits pour utiliser lesdits anticorps ou fragments de ceux-ci afin de prévenir ou traiter, par exemple, une infection à coronavirus.